192 related articles for article (PubMed ID: 9858242)
21. X-linked sideroblastic anaemia due to a mutation in the erythroid 5-aminolaevulinate synthase gene leading to an arginine170 to leucine substitution.
Edgar AJ; Vidyatilake HM; Wickramasinghe SN
Eur J Haematol; 1998 Jul; 61(1):55-8. PubMed ID: 9688293
[TBL] [Abstract][Full Text] [Related]
22. Identification of an arginine452 to histidine substitution in the erythroid 5-aminolaevulinate synthetase gene in a large pedigree with X-linked hereditary sideroblastic anaemia.
Edgar AJ; Losowsky MS; Noble JS; Wickramasinghe SN
Eur J Haematol; 1997 Jan; 58(1):1-4. PubMed ID: 9020366
[TBL] [Abstract][Full Text] [Related]
23. X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
Donker AE; Raymakers RA; Nieuwenhuis HK; Coenen MJ; Janssen MC; MacKenzie MA; Brons PP; Swinkels DW
Neth J Med; 2014 May; 72(4):210-7. PubMed ID: 24829177
[TBL] [Abstract][Full Text] [Related]
24. X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).
Bishop DF; Tchaikovskii V; Hoffbrand AV; Fraser ME; Margolis S
J Biol Chem; 2012 Aug; 287(34):28943-55. PubMed ID: 22740690
[TBL] [Abstract][Full Text] [Related]
25. [Progress of study on sideroblastic anemia and its possible gene therapy--review].
Wang YQ; Zhu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):524-8. PubMed ID: 15972158
[TBL] [Abstract][Full Text] [Related]
26. X-linked Sideroblastic Anemia in a Malay Boy With ALAS2 S568G Mutation.
Susanto TAK; Bhattacharyya R
J Pediatr Hematol Oncol; 2017 Jul; 39(5):408-409. PubMed ID: 28644307
[TBL] [Abstract][Full Text] [Related]
27. Animal models for X-linked sideroblastic anemia.
Yamamoto M; Nakajima O
Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
[TBL] [Abstract][Full Text] [Related]
28. Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia.
Morimoto Y; Chonabayashi K; Kawabata H; Okubo C; Yamasaki-Morita M; Nishikawa M; Narita M; Inagaki A; Nakanishi K; Nagao M; Takaori-Kondo A; Yoshida Y
Blood Adv; 2022 Feb; 6(4):1100-1114. PubMed ID: 34781359
[TBL] [Abstract][Full Text] [Related]
29. Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations.
Ducamp S; Kannengiesser C; Touati M; Garçon L; Guerci-Bresler A; Guichard JF; Vermylen C; Dochir J; Poirel HA; Fouyssac F; Mansuy L; Leroux G; Tertian G; Girot R; Heimpel H; Matthes T; Talbi N; Deybach JC; Beaumont C; Puy H; Grandchamp B
Hum Mutat; 2011 Jun; 32(6):590-7. PubMed ID: 21309041
[TBL] [Abstract][Full Text] [Related]
30. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
31. Pyridoxine-responsive primary acquired sideroblastic anaemia. In vitro and in vivo effects of vitamin B6 on decreased 5-aminolaevulinate synthase activity.
Meier PJ; Fehr J; Meyer UA
Scand J Haematol; 1982 Nov; 29(5):421-4. PubMed ID: 7156891
[TBL] [Abstract][Full Text] [Related]
32. Late-onset X-linked sideroblastic anemia following hemodialysis.
Furuyama K; Harigae H; Kinoshita C; Shimada T; Miyaoka K; Kanda C; Maruyama Y; Shibahara S; Sassa S
Blood; 2003 Jun; 101(11):4623-4. PubMed ID: 12531813
[TBL] [Abstract][Full Text] [Related]
33. Identification of a highly polymorphic marker within intron 7 of the ALAS2 gene and suggestion of at least two loci for X-linked sideroblastic anemia.
Cox TC; Kozman HM; Raskind WH; May BK; Mulley JC
Hum Mol Genet; 1992 Nov; 1(8):639-41. PubMed ID: 1301172
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the understanding of inherited sideroblastic anaemia.
Camaschella C
Br J Haematol; 2008 Oct; 143(1):27-38. PubMed ID: 18637800
[TBL] [Abstract][Full Text] [Related]
35. Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia.
Furuyama K; Sassa S
J Clin Invest; 2000 Mar; 105(6):757-64. PubMed ID: 10727444
[TBL] [Abstract][Full Text] [Related]
36. Multiple mechanisms for hereditary sideroblastic anemia.
Furuyama K; Sassa S
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
[TBL] [Abstract][Full Text] [Related]
37. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia.
Brownlie A; Donovan A; Pratt SJ; Paw BH; Oates AC; Brugnara C; Witkowska HE; Sassa S; Zon LI
Nat Genet; 1998 Nov; 20(3):244-50. PubMed ID: 9806542
[TBL] [Abstract][Full Text] [Related]
38. Haem synthesis in sideroblastic anaemia.
Konopka L; Hoffbrand AV
Br J Haematol; 1979 May; 42(1):73-83. PubMed ID: 465361
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.
Cotter PD; Baumann M; Bishop DF
Proc Natl Acad Sci U S A; 1992 May; 89(9):4028-32. PubMed ID: 1570328
[TBL] [Abstract][Full Text] [Related]
40. Pyridoxine-sensitive X-linked 'sideroblastic' anaemia in the absence of ring sideroblasts - molecular diagnosis.
Creasey T; Biss T; Lambert J; Smith F; Clark B; Carey P
Br J Haematol; 2018 Jan; 180(1):10. PubMed ID: 29105823
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
